France· FR:65534009
EPIRUBICINE MEDAC 2 mg/ml, solution pour perfusion
A epirubicin product containing chlorhydrate d'épirubicine, registered in France by MEDAC GESELLSCHAFT FUR KLINISCHE SPEZIALPRAPARATE (ALLEMAGNE). The same ATC class is registered in 17 of our 19 countries.
Checked against Base de données publique des médicaments — BDPM (France) on
Informational only — not a medical device.
Where it is registered
Epirubicin is registered in 17 of 19 countries.
Countries holding a registration under ATC L01DB03 (epirubicin), each read from that country’s own register.
- This record: France, from Base de données publique des médicaments — BDPM (France)
- 10 of them publish a price we can compare per daily dose
Epirubicin · ATC L01DB03
17 / 19 countries
- Belgiumprice
- Canada
- Czechiaprice
- Denmark
- Finlandprice
- Franceprice
- Germany
- Icelandprice
- Ireland
- Netherlands
- Norwayprice
- Polandprice
- Spainprice
- Sweden
- Switzerlandprice
- United Kingdom
- United Statesprice
Price per daily dose
What a daily dose of epirubicin costs, country by country.
Normalised to the WHO defined daily dose (7 mg), so markets compare like for like.
- 1 market with a comparable price for this class
- Public list prices, converted to USD at the rate date shown
Epirubicin · price per daily dose (7 mg)
USD · FX 28 Sept 2026
- CH Switzerland$15.02
The record
At a glance
Base de données publique des médicaments — BDPM (France)- Active substance
- CHLORHYDRATE D'ÉPIRUBICINE
- Manufacturer
- MEDAC GESELLSCHAFT FUR KLINISCHE SPEZIALPRAPARATE (ALLEMAGNE)
- Country
- France (FR)
- ATC code
- L01DB03
- ATC class
- Epirubicin
- Defined daily dose
- 7 mg, P
- Reimbursed
- No
- Source register
- Base de données publique des médicaments — BDPM (France)
- Last checked
- September 12, 2026
Packs & prices · 5
- cip1334009572465941 flacon(s) en verre de 5 ml
- cip1334009572467161 flacon(s) en verre de 25 ml
- cip1334009572468841 flacon(s) en verre de 50 ml
- cip1334009572469451 flacon(s) en verre de 100 ml
- cip1334009572470271 flacon(s) en verre de 200 ml
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Interactions
560 interactions on record for epirubicin.
Graded by severity as the source publishes them — 100 severe. Severity grades are free for everyone; mechanism and management come with Growth.
- Severity for every pair — free, no plan needed
- The source, licence and sync date on every record
- Mechanism and what to do for each pair — Growth plan
Epirubicin · interactions on record
560 records
- 100 severe
- 450 moderate
- 10 minor
Most severe, free to view
- CimetidineA02BA01severe
- PapaverineA03AD01severe
- CisaprideA03FA02severe
- DolasetronA04AA04severe
- Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Same medicine, other countries
Epirubicin in 15 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- NetherlandsEpirubicine HCl Pharmachemie 2 mg/ml, oplossing voor injectie of intraveneuze infusiePharmachemie B.V.
- United KingdomEpirubicin 100mg/50ml concentrate for solution for infusion vialsWockhardt UK Ltd
- BelgiumEpirubicin Eugia 2 mg/mlEugia Pharma (Malta)
- GermanyBendaepiBendalis Gmbh
- CzechiaEPIRUBICIN ACCORDACCORD HEALTHCARE POLSKA Sp. z o.o., Varšava
- SwitzerlandEpirubicin Sandoz
- FinlandEpi-CellSTADA Arzneimittel AG
- SpainEPIRUBICINA ACCORD 2 mg/ml SOLUCION INYECTABLE O PARA PERFUSION EFGAccord Healthcare S.L.U.
Authorised across Europe · EMA
The same active substance is authorised in 28 EEA countries. Names it is sold under:
- Austria · Epirubicin Accord, Epirubicin Ebewe
- Belgium · Epirubicin Ab, Epirubicin Eugia
- Bulgaria · Епирубицин Ебеве, Еписиндан
- Cyprus · Epirubicin Aqvida, Farmorubicin
- Czechia · Epirubicin Accord, Epirubicin Teva
- Germany · Bendaepi, Epi
- Denmark · Epirubicin "medac", Epirubicin Accord
- Estonia · Epirubicin Accord
- Spain · Epirubicina Accord, Epirubicina Aurovitas
- Finland · Epirubicin Accord, Epirubicin Ebewe
- United Kingdom (Northern Ireland) · Epirubicin, Epirubicin Hydrochloride Accord Healthcare
- Greece · Epirubicin Hydrochloride Pharmachemie, Epirubicin Viatris
- Hungary · Epirubicin Accord, Epirubicin Sandoz
- Ireland · Epirubicin Hydrochloride Accord Healthcare Ireland, Epirubicin Seasec Pharmaceutical
- Iceland · Epirubicin Actavis
- Italy · Epirubicina Ahcl, Epirubicina Hikma
- Lithuania · Epirubicin Accord
- Luxembourg · Epirubicin Eugia, Epirubicine Teva
- Latvia · Epirubicin Accord
- Malta · Epirubicin Hydrochloride Accord Healthcare
- Netherlands · Epirubicine Hcl Pharmachemie, Epirubicine Hikma
- Norway · Epirubicin Accord, Epirubicin Ebewe
- Poland · Epirubicin Accord, Epirubicin Ebewe
- Portugal · Epirrubicina Accord, Epirrubicina Adoh
- Romania · Epirubicină Teva
- Sweden · Epirubicin Accord, Epirubicin Ebewe
- Slovenia · Epirubicin Ebewe, Epirubicin Teva
- Slovakia · Epimedac, Epirubicín Accord
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of Base de données publique des médicaments — BDPM (France). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/f2cbde5f-bde1-435f-b9cd-b1b2d2f47eda GET /v1/drugs/f2cbde5f-bde1-435f-b9cd-b1b2d2f47eda?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"cis": "65534009",
"date_amm": "2008-03-17",
"type_amm": "Procédure nationale",
"numero_ue": null,
"substance": "CHLORHYDRATE D'ÉPIRUBICINE",
"atc_source": "fr_atc_restore_2026-09-06",
"statut_amm": "Autorisation active",
"statut_bdm": null,
"forme_pharmaceutique": "solution pour perfusion",
"voies_administration": "intraveineuse",
"etat_commercialisation": "Commercialisée",
"surveillance_renforcee": "Non"
}See everything about epirubicin.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.